Location Barcelona, Catalonia, Spain Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Obtained his Medical degree in 1991 at the Faculty of Medicine of the Autonomous University of Barcelona, where he also got his PhD in 1996 working on oncogenic signalling pathways in prostate cancer. He was a research fellow in the New York Univ. Medical Center in 1993, working on molecular mechanisms related to Ras/Raf activation in
transgenic mice.
In 1996 he moved to California as postdoctoral research at the Burnham Institute for Biomedical Research, where he work intensively in the molecular pathways involved in the development of colorectal cancer. In 2000 he was appointed as head of the Molecular Oncology and Aging laboratory at the Molecular Biology and Biochemistry Research Center for Nanomedicine (CIBBIM-Nanomedicine) of the Vall d’Hebron University Hospital in Barcelona, where he nowadays leds the “drug delivery and targeting group”. He is currently the Coordinator and Board member of the CIBBIM-Nanomedicine and also member of the Science Advisory Board of the Vall d’Hebron Research Institute (VHIR).
He is coordinator and collaborator of several research projects directly related with the obtention of therapeutic drug delivery systems, holds 12 patents and acts as Associate Director and technology transfer coordinator of the “Networking Research Centre on Bioengineering, Biomaterials and Nanomedicine” (CIBER-BBN), of the Carlos III Health Institute.
